Accounts Job 2015 Salius Pharma Pvt. Ltd recruitment notice for the post of Accounts Executive. Applicants can apply for this post to Navi Mumbai location. Candidates should have passed B.Com - Commerce from a recognized university with 2 to 4 years of experience.
Supervise payroll, billing, receivables, payable, cash receipts, cash disbursements, general ledger functions, remits tax. Able to maintain financial record keeping and reporting systems. Also should be preparing and conducting analytical review of Financial Statements.
The vacancy is for 01 position. Salary should be as per industry standards.
Position: Accounts Executive
Click Here to Subscribe
Experience: 2 to 4 years.
Location: Navi Mumbai
CTC: As per industry standards.
Qualification: Candidates should have passed B.Com - Commerce
Job Description:
- Supervise payroll, billing, receivables, payable, cash receipts, cash disbursements, general ledger functions, remits tax.
- Maintain financial record keeping and reporting systems.
- Preparing and conducting analytical review of Financial Statements.
How to apply: Process 1
• First subscribe to us by clicking the link below for continuous feedback w.r.t. Salius Pharma Pvt. Ltd job opening.
•Click Here to Subscribe (ignore if you are already subscribed).
• After subscription, you will receive an e-mail, confirm your subscription.
How to apply: Process 2
• Click here to go to career page of Salius Pharma Pvt. Ltd.
• Click on “Choose File” and upload your resume.
• Fill in the personal information.
• Press "Send Inquiry" button to send your resume to Salius Pharma Pvt. Ltd.
• We will provide feedback as and which we get the information.
Key areas related to: Accounts Executive in Salius Pharma Pvt. Ltd, Navi Mumbai Jobs, Accounts Executive vacancy in Navi Mumbai, Navi Mumbai job for Accounts Executive, Accounts Executive job.
----------------
Disclaimer: Finance naukri is a free service. Do not pay any middleman/agents/consultants for the job you are interested in. All recruitment's are solely at the discretion of the respective companies.
No comments:
Post a Comment